SDS Biotech K.K. announced consolidated earnings results for the year ended March 31, 2018. For the quarter, the company reported net sales of JPY 12,928 million as compared to JPY 12,491 million for the same period last year. Operating income was JPY 1,410 million as compared to JPY 1,263 million for the same period last year. Ordinary income was JPY 1,577 million as compared to JPY 1,316 million for the same period last year. Net loss attributable to owners of parent was JPY 180 million as compared to JPY 768 million for the same period last year. Net loss per share was JPY 23.07 as compared to JPY 98.16 for the same period last year. Loss before income taxes was JPY 466,863,000 compared to JPY 882,357,000 a year ago. Net cash provided by operating activities JPY 2,387,152,000. Purchase of property, plant and equipment was JPY 219,460,000.